European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2018
Price : $35 *
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms ECASS4-ExTEND
- 29 Nov 2017 This trial has been discontinued in Germany.
- 27 Nov 2017 This trial has been discontinued in Czech Republic.
- 01 Sep 2016 Status changed from recruiting to completed.